Ipilimumab is a monoclonal antibody and immune checkpoint inhibitor that targets CTLA-4. It is widely used in research to study T-cell activation and tumor immunology, with applications in both in vitro assays and in vivo animal models of cancer.
Concentration:
6.14 mg/mL
Molecular Weight:
148 kDa
Purity:
99.60% (May vary between batches)
CAS Number:
[477202-00-9]
Target:
Immunology/Inflammation related,Others
* VAT and and shipping costs not included. Errors and price changes excepted